DOCSLIB.ORG

Aiming for Rapid Control and Patient Cure

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Aiming for Rapid Control and Patient Cure FILARIAL DISEASES Aiming for rapid control and patient cure Filariasis is a group of infectious diseases caused microfilariae in the body. Because of this, MDA by certain thread-like parasitic worms of the must be carried out repeatedly for many years helminth (nematode) family: lymphatic filariasis until the adult worms die out naturally and (LF, or elephantiasis), onchocerciasis (river blind- no longer produce new worms. For LF MDA, ness), Loa loa (loiasis, or African eyeworm), and patients are treated once or twice a year for mansonelliasis. LF and onchocerciasis have the 4-6 years, while for onchocerciasis, MDA must highest disease burdens of the filarial diseases. be done for 10 or more years. Infecting over 150 million people around the world Second, current drugs pose life-threatening side and placing a billion people at risk, particularly effects in the LF and onchocerciasis patients who in Africa and Asia, filariae are transmitted to are co-infected with Loa loa. A small percentage humans through the bites of flies and mosqui- of patients with Loa loa have very high levels of toes. While rarely fatal, filarial diseases inflict microfilariae, and treatment with current drugs life-long disabilities on patients, such as massively can result in the sudden, massive death of these swollen limbs and genitals; blindness; chronic, juvenile Loa loa worms that overwhelms the body debilitating pain, including regular acute attacks; and causes serious adverse reactions including severe, intense itching; disfigurement; and skin brain damage (encephalopathy) and kid- discoloration (‘leopard skin’), resulting in ney failure, both of which can be fatal. depression and social stigmatization. (2) Because of this side-effect risk, Lymphatic filariasis alone is the MDA with current drugs is con- second cause of chronic disabil- sidered unacceptable in areas ity worldwide. Generally, patients where the Loa loa prevalence with filaria are often incapacitated exceeds 20%.(3) by pain or poor limb function and Therefore, a drug that can kill thus cannot work or take care of the adult onchocerciasis and LF their families or themselves. Social worms (macrofilaricide) is needed. stigmatization because of their condition A new, safe, short-course macrofilaricidal often leads to abandonment, isolation, and lack drug could be used in individual patient treatment of support from others. In short, filarial diseases (case management) at the end of MDA (known slowly destroy the lives of patients who become as ‘mopping up’), when the incidence rate is infected – physically, economically, and socially. too low to justify initiating a new MDA round. It Control strategies for filarial diseases have for could also be used in screening and treatment decades revolved around mass drug adminis- programmes, which need to be scaled up, and in tration (MDA) of donated medicines, through low-endemic areas. It could ultimately be used in programmes such as the African Programme MDA programmes to help eliminate the disease for Onchocerciasis Control (APOC) and the Global in the community with just one or two rounds of Programme to Eliminate Lymphatic Filariasis MDA treatment: patients could be cured within (GPELF). These programmes have been in place 1-2 years, rather than potentially up to 12-15 for over 20 years and rely on MDA of safe anti- years. If sufficiently safe, the new drug would parasitic drugs: ivermectin for onchocerciasis; enable the treatment of patients in areas ofLoa ivermectin, albendazole, and diethylcarbamazine loa co-infection. (DEC) for LF. Through these programmes, WHO has set goals of eliminating LF (defined as 70% of countries verified free of LF and 30% engaged Ideal Target Product Profile in post-intervention surveillance activities) and for Filarial Diseases controlling onchocerciasis by 2020.(1) A new treatment for adults and children: However, shortcomings with the currently avail- able drugs call into question whether these > Macrofilaricide: Efficacious against the adult form of worms long-running filarial control strategies, which differ according to disease and are not active in > Oral, short-course treatment low-endemic areas, will truly wipe out filaria, > No side-effects following death of worms and whether all infected patients are adequately > Safe in pregnant and breastfeeding being identified and are receiving effective treat- women ment. First, current drugs kill mainly juvenile > Affordable worms (microfilariae), which are transmitted > Adapted to tropical climates (minimum via insect vectors, but do not kill adult worms three-year shelf-life) (macrofilariae), which continue to produce new (1) Sustaining the drive to overcome the global impact of neglected tropical diseases: Second WHO report on neglected tropical diseases, World Health Organization, 2013. (2) Boussinesq M. (2006) Loiasis. Ann Trop Med Parasitol 100: 715‑31. (3) Boussinesq M. et al., (2001) Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon. Ann Trop Med Parasitol 95: 495‑507. FILARIAL DISEASES FACT SHEET WHAT IS THE IMPACT OF worm that can live for 15 years in development of nodules, and skin onchocerciasis is also endemic (i.e. FILARIAL DISEASES? the human body. The disease is disfigurement and discoloration. African countries), or Onchocerciasis (river blindness): An contracted through the bite of an Chronic LF leads to lymphoedema diethylcarbamazine (DEC) in areas estimated 25 million people are infected female blackfly, which (tissue swelling, principally of the where onchocerciasis is not infected worldwide,(1) with 99% of transmits microfilarial worms legs and genitals), elephantiasis co-endemic (i.e. non-African cases in 31 African countries. Foci (larvae) from one person to another. (skin/tissue thickening), and countries). The antibiotic drug also occur in some areas of Latin After mating, a female worm massive fluid accumulation doxycycline, while unsuitable for America (Brazil, Ecuador, releases about 1,000 new (hydrocele) in the testes. Patients use in MDA programmes because of Guatemala, Mexico, Venezuela) and microfilariae larvae per day. Larvae also suffer acute attacks of body its relatively long treatment Yemen.(2) Approximately 123 million develop into adult worms and settle pain. Physical disfigurement results duration (4-6 weeks), shows people are at risk of infection. into fibrous nodules in the human in social stigma, as well as financial promise for use in case Onchocerciasis is the world’s body close to the surface of the skin hardship from loss of income and management. second-leading infectious cause of or near the joints. increased medical expenses. LF and MDA drugs kill juvenile worms blindness.(3) The WHO estimates > LF is caused by Wuchereria onchocerciasis can cause immense (microfilariae), but not adult worms that about half a million people are bancrofti, transmitted to humans by socioeconomic burdens of isolation (macrofilariae). By killing blind due to onchocerciasis, and various mosquito species. When a and poverty. microfilariae, they can temporarily almost a million have different mosquito with infective larvae bites Loiasis leads to recurrent episodes prevent vector-borne transmission degrees of visual impairment. In a person, the parasites are of itchy swellings and to ‘eyeworm’, (until the adult worms produce endemic areas, children are deposited on the person’s skin and the visible migration of the adult more microfilariae larvae), and exposed from birth, and infection then enter the body. The larvae then worm across the surface of the eye, induce temporary sterilization of can lead to growth retardation and migrate to the lymphatic vessels which resolves after a few days but adult worms, preventing re- weight loss. where they develop into adult is itchy, painful, and causes light population with new microfilariae Lymphatic filariasis (LF; worms, damaging the lymphatic sensitivity. Subcutaneous migration for a few months. However, because elephantiasis): Over 120 million system. The worms live for 6 to of the worm causes tender, itching adult worms continue to live in the people are infected globally, with 8 years and produce millions of Calabar swelling, usually on the body, they eventually produce new about 40 million disfigured or larvae (microfilariae) that circulate limbs and near the joints. Other microfilariae, often before the next incapacitated by LF.(4) More than 1.4 in the blood. symptoms include generalized MDA, thus requiring repeated MDAs billion people in 73 countries are at > Loiasis is caused by Loa loa, the itching, muscle and joint pain, and for several years to decades until risk of infection. An estimated 25 adult worms of which can live for up fatigue. the adult worms die naturally. million men suffer genital disease, to 17 years, during which time they Ivermectin is safe and has been and over 15 million people have release millions of larvae into the WHAT ARE THE CURRENT used widely as a monotherapy in lymphoedema (swelling). The human body. These macrofilariae TREATMENTS AND THEIR MDA programmes for infection is usually acquired in migrate throughout the body just LIMITATIONS? onchocerciasis, killing the childhood, but its debilitating under the skin and sometimes Current treatments for microfilarial stage of the parasite. manifestations usually occur later cross into the subconjunctival tissue onchocerciasis and LF are based on However, in LF and onchocerciasis in life. After mental illness, LF is the of the eye where they can
Load more

Recommended publications
  • The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca Volvulus Excretory Secretory Products
    pathogens Review The Functional Parasitic Worm Secretome: Mapping the Place of Onchocerca volvulus Excretory Secretory Products Luc Vanhamme 1,*, Jacob Souopgui 1 , Stephen Ghogomu 2 and Ferdinand Ngale Njume 1,2 1 Department of Molecular Biology, Institute of Biology and Molecular Medicine, IBMM, Université Libre de Bruxelles, Rue des Professeurs Jeener et Brachet 12, 6041 Gosselies, Belgium; [email protected] (J.S.); [email protected] (F.N.N.) 2 Molecular and Cell Biology Laboratory, Biotechnology Unit, University of Buea, Buea P.O Box 63, Cameroon; [email protected] * Correspondence: [email protected] Received: 28 October 2020; Accepted: 18 November 2020; Published: 23 November 2020 Abstract: Nematodes constitute a very successful phylum, especially in terms of parasitism. Inside their mammalian hosts, parasitic nematodes mainly dwell in the digestive tract (geohelminths) or in the vascular system (filariae). One of their main characteristics is their long sojourn inside the body where they are accessible to the immune system. Several strategies are used by parasites in order to counteract the immune attacks. One of them is the expression of molecules interfering with the function of the immune system. Excretory-secretory products (ESPs) pertain to this category. This is, however, not their only biological function, as they seem also involved in other mechanisms such as pathogenicity or parasitic cycle (molting, for example). Wewill mainly focus on filariae ESPs with an emphasis on data available regarding Onchocerca volvulus, but we will also refer to a few relevant/illustrative examples related to other worm categories when necessary (geohelminth nematodes, trematodes or cestodes).
    [Show full text]
  • Eisai Announces Results and Continued Support Of
    No.17-18 April 19, 2017 Eisai Co., Ltd. EISAI ANNOUNCES RESULTS AND CONTINUED SUPPORT OF INITIATIVES FOR ELIMINATION OF LYMPHATIC FILARIASIS 5 YEAR ANNIVERSARY OF LONDON DECLARATION ON NEGLECTED TROPICAL DISEASES Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) has announced the results of its initiatives for the elimination of lymphatic filariasis (LF), and its continued support of this cause in the future. This announcement was made at an event held in Geneva, Switzerland, on April 18, marking the 5th anniversary of the London Declaration on Neglected Tropical Diseases (NTDs), an international public-private partnership. Announced in January 2012, the London Declaration is the largest public-private partnership in the field of global health, and represents a coordinated effort by global pharmaceutical companies, the Bill & Melinda Gates Foundation, the World Health Organization (WHO), the United States, United Kingdom and NTD-endemic country governments, as well as other partners, to eliminate 10 NTDs by the year 2020. Since the signing of the London Declaration, donations of medical treatments by pharmaceutical companies have increased by 70 percent, and these treatments contribute to the prevention and cure of disease in approximately 1 billion people every year. Under the London Declaration, Eisai signed an agreement with WHO to supply 2.2 billion high-quality diethylcarbamazine (DEC) tablets, which were running in short supply worldwide, at Price Zero (free of charge) by the year 2020. These DEC tablets are manufactured at Eisai’s Vizag Plant in India. As of the end of March 2017, 1 billion tablets have been supplied to 27 endemic countries.
    [Show full text]
  • Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being
    Research and Reviews on Healthcare: Open Access Journal DOI: 10.32474/RRHOAJ.2020.06.000226 ISSN: 2637-6679 Research Article Pathophysiology and Gastrointestinal Impacts of Parasitic Helminths in Human Being Firew Admasu Hailu1*, Geremew Tafesse1 and Tsion Admasu Hailu2 1Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia 2Addis Ababa Medical and Business College, Addis Ababa, Ethiopia *Corresponding author: Firew Admasu Hailu, Dilla University, College of Natural and Computational Sciences, Department of Biology, Dilla, Ethiopia Received: November 05, 2020 Published: November 20, 2020 Abstract Introduction: This study mainly focus on the major pathologic manifestations of human gastrointestinal impacts of parasitic worms. Background: Helminthes and protozoan are human parasites that can infect gastrointestinal tract of humans beings and reside in intestinal wall. Protozoans are one celled microscopic, able to multiply in humans, contributes to their survival, permits serious infections, use one of the four main modes of transmission (direct, fecal-oral, vector-borne, and predator-prey) and also helminthes are necked multicellular organisms, referred as intestinal worms even though not all helminthes reside in intestines. However, in their adult form, helminthes cannot multiply in humans and able to survive in mammalian host for many years due to their ability to manipulate immune response. Objectives: The objectives of this study is to assess the main pathophysiology and gastrointestinal impacts of parasitic worms in human being. Methods: Both primary and secondary data were collected using direct observation, books and articles, and also analyzed quantitativelyResults and and conclusion: qualitatively Parasites following are standard organisms scientific living temporarily methods. in or on other organisms called host like human and other animals.
    [Show full text]
  • Co-Infection with Onchocerca Volvulus and Loa Loa Microfilariae in Central Cameroon: Are These Two Species Interacting?
    843 Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting? S. D. S. PION1,2*, P. CLARKE3, J. A. N. FILIPE2,J.KAMGNO1,J.GARDON1,4, M.-G. BASA´ N˜ EZ2 and M. BOUSSINESQ1,5 1 Laboratoire mixte IRD (Institut de Recherche pour le De´veloppement) – CPC (Centre Pasteur du Cameroun) d’Epide´miologie et de Sante´ publique, Centre Pasteur du Cameroun, BP 1274, Yaounde´, Cameroun 2 Department of Infectious Disease Epidemiology, St Mary’s campus, Norfolk Place, London W2 1PG, UK 3 Infectious Disease Epidemiology Unit London School of Hygiene and Tropical Medicine Keppel Street, London WC1E 7HT, UK 4 Institut de Recherche pour le De´veloppement, UR 24 Epide´miologie et Pre´vention, CP 9214 Obrajes, La Paz, Bolivia 5 Institut de Recherche pour le De´veloppement, De´partement Socie´te´s et Sante´, 213 rue La Fayette, 75480 Paris Cedex 10, France (Received 16 August 2005; revised 3 October; revised 9 December 2005; accepted 9 December 2005; first published online 10 February 2006) SUMMARY Ivermectin treatment may induce severe adverse reactions in some individuals heavily infected with Loa loa. This hampers the implementation of mass ivermectin treatment against onchocerciasis in areas where Onchocerca volvulus and L. loa are co-endemic. In order to identify factors, including co-infections, which may explain the presence of high L. loa micro- filaraemia in some individuals, we analysed data collected in 19 villages of central Cameroon. Two standardized skin snips and 30 ml of blood were obtained from each of 3190 participants and the microfilarial (mf) loads of both O.
    [Show full text]
  • SNF Mobility Model: ICD-10 HCC Crosswalk, V. 3.0.1
    The mapping below corresponds to NQF #2634 and NQF #2636. HCC # ICD-10 Code ICD-10 Code Category This is a filter ceThis is a filter cellThis is a filter cell 3 A0101 Typhoid meningitis 3 A0221 Salmonella meningitis 3 A066 Amebic brain abscess 3 A170 Tuberculous meningitis 3 A171 Meningeal tuberculoma 3 A1781 Tuberculoma of brain and spinal cord 3 A1782 Tuberculous meningoencephalitis 3 A1783 Tuberculous neuritis 3 A1789 Other tuberculosis of nervous system 3 A179 Tuberculosis of nervous system, unspecified 3 A203 Plague meningitis 3 A2781 Aseptic meningitis in leptospirosis 3 A3211 Listerial meningitis 3 A3212 Listerial meningoencephalitis 3 A34 Obstetrical tetanus 3 A35 Other tetanus 3 A390 Meningococcal meningitis 3 A3981 Meningococcal encephalitis 3 A4281 Actinomycotic meningitis 3 A4282 Actinomycotic encephalitis 3 A5040 Late congenital neurosyphilis, unspecified 3 A5041 Late congenital syphilitic meningitis 3 A5042 Late congenital syphilitic encephalitis 3 A5043 Late congenital syphilitic polyneuropathy 3 A5044 Late congenital syphilitic optic nerve atrophy 3 A5045 Juvenile general paresis 3 A5049 Other late congenital neurosyphilis 3 A5141 Secondary syphilitic meningitis 3 A5210 Symptomatic neurosyphilis, unspecified 3 A5211 Tabes dorsalis 3 A5212 Other cerebrospinal syphilis 3 A5213 Late syphilitic meningitis 3 A5214 Late syphilitic encephalitis 3 A5215 Late syphilitic neuropathy 3 A5216 Charcot's arthropathy (tabetic) 3 A5217 General paresis 3 A5219 Other symptomatic neurosyphilis 3 A522 Asymptomatic neurosyphilis 3 A523 Neurosyphilis,
    [Show full text]
  • Hookworm-Related Cutaneous Larva Migrans
    326 Hookworm-Related Cutaneous Larva Migrans Patrick Hochedez , MD , and Eric Caumes , MD Département des Maladies Infectieuses et Tropicales, Hôpital Pitié-Salpêtrière, Paris, France DOI: 10.1111/j.1708-8305.2007.00148.x Downloaded from https://academic.oup.com/jtm/article/14/5/326/1808671 by guest on 27 September 2021 utaneous larva migrans (CLM) is the most fre- Risk factors for developing HrCLM have specifi - Cquent travel-associated skin disease of tropical cally been investigated in one outbreak in Canadian origin. 1,2 This dermatosis fi rst described as CLM by tourists: less frequent use of protective footwear Lee in 1874 was later attributed to the subcutane- while walking on the beach was signifi cantly associ- ous migration of Ancylostoma larvae by White and ated with a higher risk of developing the disease, Dove in 1929. 3,4 Since then, this skin disease has also with a risk ratio of 4. Moreover, affected patients been called creeping eruption, creeping verminous were somewhat younger than unaffected travelers dermatitis, sand worm eruption, or plumber ’ s itch, (36.9 vs 41.2 yr, p = 0.014). There was no correla- which adds to the confusion. It has been suggested tion between the reported amount of time spent on to name this disease hookworm-related cutaneous the beach and the risk of developing CLM. Consid- larva migrans (HrCLM).5 ering animals in the neighborhood, 90% of the Although frequent, this tropical dermatosis is travelers in that study reported seeing cats on the not suffi ciently well known by Western physicians, beach and around the hotel area, and only 1.5% and this can delay diagnosis and effective treatment.
    [Show full text]
  • Comparative Genomics of the Major Parasitic Worms
    Comparative genomics of the major parasitic worms International Helminth Genomes Consortium Supplementary Information Introduction ............................................................................................................................... 4 Contributions from Consortium members ..................................................................................... 5 Methods .................................................................................................................................... 6 1 Sample collection and preparation ................................................................................................................. 6 2.1 Data production, Wellcome Trust Sanger Institute (WTSI) ........................................................................ 12 DNA template preparation and sequencing................................................................................................. 12 Genome assembly ........................................................................................................................................ 13 Assembly QC ................................................................................................................................................. 14 Gene prediction ............................................................................................................................................ 15 Contamination screening ............................................................................................................................
    [Show full text]
  • Genomics of Loa Loa, a Wolbachia-Free Filarial Parasite of Humans
    ARTICLES OPEN Genomics of Loa loa, a Wolbachia-free filarial parasite of humans Christopher A Desjardins1, Gustavo C Cerqueira1, Jonathan M Goldberg1, Julie C Dunning Hotopp2, Brian J Haas1, Jeremy Zucker1, José M C Ribeiro3, Sakina Saif1, Joshua Z Levin1, Lin Fan1, Qiandong Zeng1, Carsten Russ1, Jennifer R Wortman1, Doran L Fink4,5, Bruce W Birren1 & Thomas B Nutman4 Loa loa, the African eyeworm, is a major filarial pathogen of humans. Unlike most filariae, L. loa does not contain the obligate intracellular Wolbachia endosymbiont. We describe the 91.4-Mb genome of L. loa and that of the related filarial parasite Wuchereria bancrofti and predict 14,907 L. loa genes on the basis of microfilarial RNA sequencing. By comparing these genomes to that of another filarial parasite, Brugia malayi, and to those of several other nematodes, we demonstrate synteny among filariae but not with nonparasitic nematodes. The L. loa genome encodes many immunologically relevant genes, as well as protein kinases targeted by drugs currently approved for use in humans. Despite lacking Wolbachia, L. loa shows no new metabolic synthesis or transport capabilities compared to other filariae. These results suggest that the role of Wolbachia in filarial biology is more subtle All rights reserved. than previously thought and reveal marked differences between parasitic and nonparasitic nematodes. Filarial nematodes dwell within the lymphatics and subcutaneous (but not the worm itself) have shown efficacy in treating humans tissues of up to 170 million people worldwide and are responsible with these infections4,5. Through genomic analysis, Wolbachia have for notable morbidity, disability and socioeconomic loss1.
    [Show full text]
  • The Immunology of Filariasis*
    Articles in the Update series Les articles de la rubrique give a concise, authoritative, Le point fournissent un and up-to-date survey of the bilan concis et fiable de la present position in the se- situation actuelle dans le a e lected fields, and, over a domaine considere. Des ex- ,,v period of years, will cover / perts couvriront ainsi suc- / many different aspects of cessivement de nombreux the biomedical sciences aspects des sciences bio- e nVlfo l l gZ / / and public health. Most of medicales et de la sante the articles will be writ- publique. La plupart de ces ten, by invitation, by ac- articles auront donc ee knowledged experts on the rediges sur demande par les subject. specialistes les plus autorises. Bulletin of the World Health Organization, 59 (1): 1-8 (1981) The immunology of filariasis* SCIENTIFIC WORKING GROUP ON FILARIASIS1 This report summarizes the available information on the immunology of filariasis, and discusses immunodiagnosis and the immunologicalfactors influencing the host-parasite relationship in lymphaticfilariasis and onchocerciasis. Severalareas that requirefurther research are identifed, particularly concerning the development of new serological techniques, and the fractionation of specific antigens. The problems associated with vaccine development are considered and the importance of finding better animal modelsfor research is stressed. Lymphatic filariasis and onchocerciasis are recognized as important public health problems in many tropical and subtropical areas. However, until recently, little was known about the natural history of filariasis or the immune mechanisms involved. This report summarizes current knowledge on various aspects of the immunology of the disease and outlines areas for future research.
    [Show full text]
  • Helminth Parasites of the Common Grackle Quiscalus Quiscula Versicolor Vieillot in Indiana
    This dissertation has been 62—3609 microfilmed exactly as received WELKER, George William, 1923- HELMINTH PARASITES OF THE COMMON GRACKLE QUISCALUS QUISCULA VERSICOLOR VIEILLOT IN INDIANA. The Ohio State University, Ph.D., 1962 Zoology University Microfilms, Inc., Ann Arbor, Michigan HELMINTH PARASITES OP THE COMMON GRACKLE QUISCALU5 QUISCULA VERSICOLOR VIEILLOT IN INDIANA DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By George William Welker, B. S., M. A. u _ u u u The Ohio State University 1962 Approved by: 1'XJijdJi ~7 Adviser urtameenhtt of Zoology and Entomology Dedicated as a tribute of appreciation and admiration to ELLEN ANN, my wife, for her help and for the sacrifices which she made during the four years covered by this study. ii ACKNOWLEDGMENTS The author wishes to express his sincere appreciation for all the help and cooperation which he has received from many people during the course of this study: Dr. Joseph Jones, Jr. of St. Augustine's College, Raleigh, North Carolina; Dr. Donal Myer, Southern Illinois university; Dr. E. J. Robinson, Jr., Kenyon College, Gambier, Ohio; Dr. Martin J. Ulmer, Iowa State University, Ames, Iowa; and Dr. A. Carter Broad and Dr. Carl Reese of the reading committee who helped in checking the paper for errors. Special acknowledgment goes to two persons whose help and influence are most deeply appreciated. To Professor Robert H. Cooper, Head of the Department of Science at Ball State Teachers College, whose sincere and continuous interest, encouragement and help made possible the completion of the work; and to Professor Joseph N.
    [Show full text]
  • 1 Summary of the Thirteenth Meeting of the ITFDE (II) October 29, 2008
    Summary of the Thirteenth Meeting of the ITFDE (II) October 29, 2008 The Thirteenth Meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 8:30am to 4:00 pm on October 29, 2008. Topics discussed at this meeting were the status of the global campaigns to eliminate lymphatic filariasis (LF) and to eradicate dracunculiasis (Guinea worm disease), an update on efforts to eliminate malaria and LF from the Caribbean island of Hispaniola (Dominican Republic and Haiti), and a report on the First Program Review for Buruli ulcer programs. The Task Force members are Dr. Olusoji Adeyi, The World Bank; Sir George Alleyne, Johns Hopkins University; Dr. Julie Gerberding, Centers for Disease Control and Prevention (CDC); Dr. Donald Hopkins, The Carter Center (Chair); Dr. Adetokunbo Lucas, Harvard University; Professor David Molyneux, Liverpool School of Tropical Medicine (Rtd.); Dr. Mark Rosenberg, Task Force for Child Survival and Development; Dr. Peter Salama, UNICEF; Dr. Lorenzo Savioli, World Health Organization (WHO); Dr. Harrison Spencer, Association of Schools of Public Health; Dr. Dyann Wirth, Harvard School of Public Health, and Dr. Yoichi Yamagata, Japan International Cooperation Agency (JICA). Four of the Task Force members (Hopkins, Adeyi, Lucas, Rosenberg) attended this meeting, and three others were represented by alternates (Dr. Stephen Blount for Gerberding, Dr. Mark Young for Dr. Salama, Dr. Dirk Engels for Savioli). Presenters at this meeting were Dr. Eric Ottesen of the Task Force for Child Survival and Development, Dr. Patrick Lammie of the CDC, Dr. Ernesto Ruiz-Tiben of The Carter Center, Dr. David Joa Espinal of the National Center for Tropical Disease Control (CENCET) in the Dominican Republic, and Dr.
    [Show full text]
  • 2. Studies on the Multiplication of Chkunya Virus (CHV), and on Physical and Chemical Structure of Its Virion
    71 PAPER IN SCIENTIFIC SESSION GROUP A: Immunology and Viral Diseases 1. Principles and Applications of Fluorescent Antibody Technique in Tropical Medicine Akira Kawamura Department of Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan 2. Studies on the Multiplication of Chkunya Virus (CHV), and on Physical and Chemical Structure of its Virion Noboru Higashi,Yasuko Nagatomo, Akira Tamura and Toshio Ametani Virus Institute, Kyoto University, Kyoto, Japan 3. Electronmicroscopic Studies on the Multiplications of Japanese Encephalitis Viurs Noboru Higashi*, Toshiko Ametani*, Yasuko Nagatomo*, Eiichi Fujiwara* and Takashi Tsuruhara** *Virus Institute, Kyoto Uniuersity, Kyoto, Japan and **NIH of Japan , Tokyo, Japan 4. Electromicroscopic Studies on the Multiplication of Dengue Virus Noboru Higashi*, Masao Tokuda*, Toshio Ametani*, Mya-Tu, My My Khin** and Toe Myint** *Virus Institute, Kyoto University, Kyoto, Japan and **Viral Section , Burma Medical Institute, Buruma 72 5. A Plaque Assay of Dengue and Other Arboviruses in Monolayer Cultures of BHK-21 Cells Hideo Aoki Department of Microbiology, School of Medicine Kobe University, Kobe, Japan A cell line of baby hamster kidney (BHK-21, clone 13) was found suitable for titration and multiplication of many kinds of arboviruses, including all types of dengue and related viruses. For instance, dengue (type 1, Hawaiian, Mochizuki ; type 2, New Guinea B ; type 3, H-87 ; type 4, H-241 ; type 5 ? Th-36 ; type 6 ? Th-Sman), JBE Nakayama, JaGar # 01, Gl) and Chikungunya (African) viruses are capable of producing clear plaques in monolayer cultures of the cells under a methyl cellulose overlay medium. By means of this plaque assay system, titration and neutralization of these arboviruses are possible.
    [Show full text]